Firehose

Anthropic has made early progress in accelerating drug development with Claude, a proprietary AI model, through partnerships with six organizations, including BigHat Biosciences, Bristol Myers Squibb, and Divergence Labs. Claude has been applied to various tasks, such as proposing initial designs for new molecules, generating antibody designs, and optimizing drug properties, resulting in improved outcomes and reduced time for human reviewers. AI summary